A better screening
Transforming the linkage to care
MagIA diagnostics Point-of-care screening will transform the way patients are linked to care
Multiplexed
Fast
Small sample
Portable
Syndromic testing
MagIA diagnostics offers a new approach allowing the screening of HIV and its coinfections hepatitis B and C in a single test using capillary blood. With its ability to test 2 cartridges at the same time, our system to test up to 8 markers at the point of care. Our portable and syndromic approach provides benefits to healthcare professionals allowing more people to be tested in less time, resulting in a better linkage to care of the patients.
One system – endless testing
MagIA diagnostics will offer a large panel of syndromic testing panels – all based on the same analyzer
Latest news
The latest updates from MagIA diagnostics
Le projet MAGFA obtient un financement européen
[hashtag#LBPmember] 📢 Le projet MAGFA reçoit un financement européen de 5 millions d’Euros. Ce projet, accompagné par Lyonbiopôle Auvergne-Rhône-Alpes, est porté par la société MagIA diagnostics en collaboration avec l’Institut Pasteur ainsi que 5 acteurs d’Afrique...
Read our feature on MLFIA to MagIA in SLAS magazine
Read the article “From a research platform (MLFIA) to a multiplexed POC system (MagIA)” in the June issue of SLAS magazine. Thanks to SLAS (Society for Laboratory Automation and Screening) for this highlight. Découvrez l'article : "From a research platform (MLFIA) to...
MAGICIEN clinical study!
EN| Here we go! We are entering Phase 3 of our MAGICIEN clinical study! Thursday, Paul and Damien went to the European Hospital of Marseille to launch this third phase where around 50 patients will be tested. Our goal: to validate the sensitivity and specificity of...